FIREFISH Part 2: 24-Month Efficacy and Safety of Risdiplam in Infants with Type 1 Spinal Muscular Atrophy (SMA)

Autor:	Maria Mazurkiewicz-Bełdzińska, Marianne Gerber, Heidemarie Kletzl, R. Masson, Andrea Klein, Edmar Zanoteli, Ksenija Gorni, Basil T. Darras, Kristy Rose, Giovanni Baranello, Laurent Servais, H. Xiong, D. Vlodavets, A. Dodman, M. El-Khairi, Renata S. Scalco
Rok vydání:	2021
Předmět:	business.industry Anesthesia medicine Spinal muscular atrophy medicine.disease SMA business
Zdroj:	Abstracts of the 46th Annual Meeting of the Society for Neuropediatrics.
ISSN:	1439-1899
DOI:	10.1055/s-0041-1739636
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::89e5acac415f97f435c35a50acd74960 https://doi.org/10.1055/s-0041-1739636 Zobrazit plný text záznamu